Chronic myeloid leukemia (CML) is a type of blood and marrow cancer that is associated with a unique genetic abnormality in the blood and bone marrow called the Philadelphia Chromosome. This genetic abnormality is responsible for the development of this leukemia.
Chronic myeloid leukemia represents approximately 15 percent of all leukemia among adults.
Why choose the Cancer Therapy & Research Center (CTRC) for chronic myeloid leukemia?
We pride ourselves on the multidisciplinary approach we bring to each cancer case and we work hard to give you an individualized treatment plan that you are involved in designing. Hematologists who specialize in blood cancers provide care for patients in clinics and hospital-based units designed for patients with leukemia. Our work begins with a rapid comprehensive evaluation and discussion with a team that includes pathologists specializing in blood, marrow, and lymph node cancers, called hemato-pathologists.
Clinical trials at the CTRC
As a cancer center designated by the National Cancer Institute (NCI), the CTRC is able to offer clinical trials in situations where such an option would be beneficial. Your treatment team can help you decide if a clinical trial should be an option for you and the team can help you understand the steps involved in participating in a clinical trial.
Make an appointment
To request an appointment with our team or to make a referral to one of our physicians, please call the CTRC main number: (210) 450-1000 or 800-340-2872 or email CTRCReferral@uthscsa.edu.